Atlas Trials

Evaluation of a Plasma Marker (p-Tau217) for the Biological Diagnosis of Alzheimer's Disease, and Comparison With CSF Markers

Clinical trial NCT07071649 · RECRUITING

Trial details

NCT number
NCT07071649
Sponsor
Centre Hospitalier Universitaire, Amiens
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Alzheimer's DiseaseBiomarkersNon-invasive DiagnosisPhosphorylated Protein p-tau217
Start date
2025-11-20
Primary completion
2027-02-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.